Swedish Drug-elution Trial in Peripheral Arterial Disease (SWEDEPAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02051088

Recruitment Status : Active, not recruiting

First Posted : January 31, 2014

Last Update Posted : December 19, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

The Swedish Research Council

Swedish Heart Lung Foundation

Uppsala University

The Swedish National Registry for Vascular Surgery

Information provided by (Responsible Party):

Mårten Falkenberg, Sahlgrenska University Hospital, Sweden

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	November 2024
Estimated Study Completion Date :	December 2024

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Nordanstig J, James S, Andersson M, Andersson M, Danielsson P, Gillgren P, Delle M, Engstrom J, Fransson T, Hamoud M, Hilbertson A, Johansson P, Karlsson L, Kragsterman B, Lindgren H, Ludwigs K, Mellander S, Nyman N, Renlund H, Sigvant B, Skoog P, Starck J, Tegler G, Toivola A, Truedson M, Wahlgren CM, Wallinder J, Ojersjo A, Falkenberg M. Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease. N Engl J Med. 2020 Dec 24;383(26):2538-2546. doi: 10.1056/NEJMoa2005206. Epub 2020 Dec 9.

To Top